|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
13 June 2016 |
|
Main ID: |
NCT01562665 |
|
Date of registration:
|
22/02/2012 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Epidemiological Study to Describe Non Small Cell Lung Cancer Clinical Management Patterns in MENA. Lung-EPICLIN/ Gulf
Lung-EPICLIN/G |
|
Scientific title:
|
Epidemiological Study to Describe NSCLC Clinical Management Patterns in MENA |
|
Date of first enrolment:
|
June 2012 |
|
Target sample size:
|
25 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT01562665 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case-Only, Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Bahrain
|
Qatar
|
United Arab Emirates
| | | | | |
|
Contacts
|
|
Name:
|
Mohamed Jaloudy, CONSULTANT |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Tawam Hospital ,Alain,Abu Dhabi, United Arab Emirates |
|
|
Name:
|
Farid Khalifa, CONSULTANT |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Salmaniya Medical Complex, Bahrain |
|
|
Name:
|
Norbert Drier, CONSULTANT |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Zayed Military Hospital, Abu Dhabi, United Arab Emirates |
|
|
Name:
|
Ahmed El Khodary, CONSULTANT |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Kuwait Cancer Centre, Al Sabah Hospital, Kuwait |
|
|
Name:
|
Kakil Rasul, CONSULTANT |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Hamad Medical Corporation, Doha, Qatar |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Confirmed NSCLC diagnosis (e.g. bronchoscope or FNAB), all stages, men and women,
attending the responsible department of treating this type of patients for the first
time between November 1st, 2011 and August 30th, 2012 For PRO
- Sub-sample:
- ability to read and write since they will be asked to participate in the PRO
part of the study.
- Selection will not be based on the disease stage of each patient, in order to avoid a
selection bias.
Exclusion Criteria:
- According to the study design there will not be any exclusion criteria in order to
provide a high validity and to obtain the most accurate real daily practice
information.
Age minimum:
N/A
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Non Small Cells Lung Cancer
|
|
Primary Outcome(s)
|
|
Use of health resources by collecting data about hospital description and characteristics, Disease Diagnosis Procedures and Therapy information
[Time Frame: April 2014(26 Months)]
|
|
Secondary Outcome(s)
|
|
Patient-Reported Outcomes (PRO) through self-administered questionnaires and the patients will be asked to complete them at each evaluation visit(25% of the whole sample)
[Time Frame: April 2014(26 Months)]
|
|
Secondary ID(s)
|
|
NIS-OAE-XXX-2011/1
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|